Houeto JL - Search Results

1

Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.

Moreau C, Meguig S, Corvol JC, Labreuche J, Vasseur F, Duhamel A, Delval A, Bardyn T, Devedjian JC, Rouaix N, Petyt G, Brefel-Courbon C, Ory-Magne F, Guehl D, Eusebio A, Fraix V, Saulnier PJ, Lagha-Boukbiza O, Durif F, Faighel M, Giordana C, Drapier S, Maltête D, Tranchant C, Houeto JL, Debû B, Azulay JP, Tison F, Destée A, Vidailhet M, Rascol O, Dujardin K, Defebvre L, Bordet R, Sablonnière B, Devos D; Parkgait-II Study Group. Moreau C, et al. Among authors: houeto jl. Brain. 2015 May;138(Pt 5):1271-83. doi: 10.1093/brain/awv063. Epub 2015 Mar 23. Brain. 2015. PMID: 25805645 Free PMC article. Clinical Trial.

2

Subthalamic stimulation in Parkinson disease: a multidisciplinary approach.

Houeto JL, Damier P, Bejjani PB, Staedler C, Bonnet AM, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Houeto JL, et al. Arch Neurol. 2000 Apr;57(4):461-5. doi: 10.1001/archneur.57.4.461. Arch Neurol. 2000. PMID: 10768618 Clinical Trial.

3

Abnormal reciprocal inhibition between antagonist muscles in Parkinson's disease.

Meunier S, Pol S, Houeto JL, Vidailhet M. Meunier S, et al. Among authors: houeto jl. Brain. 2000 May;123 ( Pt 5):1017-26. doi: 10.1093/brain/123.5.1017. Brain. 2000. PMID: 10775546

4

Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?

Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y. Bejjani BP, et al. Among authors: houeto jl. Ann Neurol. 2000 May;47(5):655-8. Ann Neurol. 2000. PMID: 10805339

5

Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.

Pillon B, Ardouin C, Damier P, Krack P, Houeto JL, Klinger H, Bonnet AM, Pollak P, Benabid AL, Agid Y. Pillon B, et al. Among authors: houeto jl. Neurology. 2000 Aug 8;55(3):411-8. doi: 10.1212/wnl.55.3.411. Neurology. 2000. PMID: 10932277 Clinical Trial.

6

Clinical predictive factors of subthalamic stimulation in Parkinson's disease.

Welter ML, Houeto JL, Tezenas du Montcel S, Mesnage V, Bonnet AM, Pillon B, Arnulf I, Pidoux B, Dormont D, Cornu P, Agid Y. Welter ML, et al. Among authors: houeto jl. Brain. 2002 Mar;125(Pt 3):575-83. doi: 10.1093/brain/awf050. Brain. 2002. PMID: 11872614

7

Parkinson's disease and sleepiness: an integral part of PD.

Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y. Arnulf I, et al. Among authors: houeto jl. Neurology. 2002 Apr 9;58(7):1019-24. doi: 10.1212/wnl.58.7.1019. Neurology. 2002. PMID: 11940685

8

Parkinson's disease is a neuropsychiatric disorder.

Agid Y, Arnulf I, Bejjani P, Bloch F, Bonnet AM, Damier P, Dubois B, François C, Houeto JL, Iacono D, Karachi C, Mesnage V, Messouak O, Vidailhet M, Welter ML, Yelnik J. Agid Y, et al. Among authors: houeto jl. Adv Neurol. 2003;91:365-70. Adv Neurol. 2003. PMID: 12442695 Review. No abstract available.

9

Subthalamic stimulation in Parkinson disease: intraoperative predictive factors.

Houeto JL, Welter ML, Bejjani PB, Tezenas du Montcel S, Bonnet AM, Mesnage V, Navarro S, Pidoux B, Dormont D, Cornu P, Agid Y. Houeto JL, et al. Arch Neurol. 2003 May;60(5):690-4. doi: 10.1001/archneur.60.5.690. Arch Neurol. 2003. PMID: 12756132

10

Subthalamic stimulation in Parkinson disease: with or without anesthesia?

Maltête D, Navarro S, Welter ML, Roche S, Bonnet AM, Houeto JL, Mesnage V, Pidoux B, Dormont D, Cornu P, Agid Y. Maltête D, et al. Among authors: houeto jl. Arch Neurol. 2004 Mar;61(3):390-2. doi: 10.1001/archneur.61.3.390. Arch Neurol. 2004. PMID: 15023817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

156 results

Search Page